Pharmaceutico-Analytical Evaluation of Ashwagandha Tablet – A Contemporary Ayurveda Dosage Form commonly used in Psychiatric Disorders
DOI:
https://doi.org/10.69980/ajpr.v28i1.171Keywords:
Ashwagandha, Withania somnifera, Ayurvedic tablet, pharmaceutico-analytica, TLC, phytochemical, RasayanaAbstract
Ashwagandha (Withania somnifera), a revered Rasayana herb in Ayurveda, is renowned for its adaptogenic, neuroprotective, and immunomodulatory properties. With the growing global interest in traditional medicine and integrative healthcare, there is an increasing demand for standardized, safe, and efficacious herbal formulations. This study presents a comprehensive pharmaceutico-analytical evaluation of an Ashwagandha tablet formulation developed at KLE Ayurveda Pharmacy, Belagavi, with the aim of assessing its quality, consistency, and therapeutic viability. The evaluation encompassed organoleptic examination, physicochemical testing, preliminary phytochemical screening, and Thin Layer Chromatography (TLC) profiling, following Ayurvedic Pharmacopoeia and general analytical protocols. The tablet displayed characteristic color, odor, and bitterness, correlating well with the properties of authentic Ashwagandha root. Physicochemical parameters, including loss on drying, ash values, extractive values, friability, disintegration time, and hardness, were within pharmaceutically acceptable limits. Phytochemical analysis revealed the presence of key secondary metabolites such as flavonoids, tannins, steroids, and glycosides, while TLC fingerprinting confirmed a consistent chemical profile. The results support the formulation’s stability, purity, and potential therapeutic efficacy, especially in the management of stress-related, cognitive, and psychiatric conditions. By demonstrating compliance with both classical Ayurvedic and modern analytical standards, this study underscores the feasibility of integrating traditional herbal knowledge into contemporary dosage forms. The findings advocate for the continued scientific validation and standardization of Ayurvedic medicines to enhance their credibility and accessibility in global healthcare systems.
References
1. Patwardhan, B., Warude, D., Pushpangadan, P., & Bhatt, N. (2005). Ayurveda and traditional Chinese medicine: a comparative overview. Evidence-Based Complementary and Alternative Medicine, 2(4), 465–473.
2. Panda, S., & Kar, A. (1998). Changes in thyroid hormone concentrations after administration of Ashwagandha root extract to adult male mice. Journal of Pharmacy and Pharmacology, 50(9), 1065–1068.
3. Sharma, P. V. (1996). Dravyaguna Vijnana (Vol. 2). Chaukhambha Bharati Academy.
4. Singh, N., Bhalla, M., Jager, P. D., & Gilca, M. (2011). An overview on Ashwagandha: a Rasayana (rejuvenator) of Ayurveda. African Journal of Traditional, Complementary and Alternative Medicines, 8(5S), 208–213.
5. Chandrasekhar, K., Kapoor, J., & Anishetty, S. (2012). A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of Ashwagandha root in reducing stress and anxiety in adults. Indian Journal of Psychological Medicine, 34(3), 255–262.
6. Lopresti, A. L., & Drummond, P. D. (2017). Efficacy of Ashwagandha (Withania somnifera) in improving sexual function in women: a pilot study. BioMed Research International, 2017, 1–8.
7. Kulkarni, R. R., Patki, P. S., Jog, V. P., Gandage, S. G., & Patwardhan, B. (1991). Treatment of osteoarthritis with a herbomineral formulation: a double-blind, placebo-controlled, cross-over study. Journal of Ethnopharmacology, 33(1–2), 91–95.
8. Devi, P. U., Sharada, A. C., & Solomon, F. E. (1992). Antitumor and radiosensitizing effects of Withania somnifera (Ashwagandha) root extract on fibrosarcoma in mice. International Journal of Radiation Biology, 61(6), 609–612.
9. Ayurvedic Pharmacopoeia of India. (2008). Part I, Volume III. Government of India, Ministry of AYUSH.
10. WHO. (2011). Quality Control Methods for Herbal Materials (Updated Edition). World Health Organization.
11. Mishra, L. C., Singh, B. B., & Dagenais, S. (2000). Scientific basis for the therapeutic use of Withania somnifera (Ashwagandha): a review. Alternative Medicine Review, 5(4), 334–346.
12. Bhattacharya, S. K., Bhattacharya, D., Sairam, K., & Ghosal, S. (2000). Anxiolytic-antidepressant activity of Withania somnifera glycowithanolides: an experimental study. Phytomedicine, 7(6), 463–469.
13. Chandrasekhar, K., Kapoor, J., & Anishetty, S. (2012). A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of Ashwagandha root in reducing stress and anxiety in adults. Indian Journal of Psychological Medicine, 34(3), 255–262.
14. Salve, J., Pate, S., Debnath, K., & Langade, D. (2019). Adaptogenic and anxiolytic effects of Ashwagandha root extract in healthy adults: a double-blind, randomized, placebo-controlled clinical study. Cureus, 11(12), e6466.
15. Andrade, C., Aswath, A., Chaturvedi, S. K., Srinivasa, M., & Raguram, R. (2000). A double-blind, placebo-controlled evaluation of the anxiolytic efficacy of an ethanolic extract of Withania somnifera. Indian Journal of Psychiatry, 42(3), 295–301.
16. Cooley, K., Szczurko, O., Perri, D., Mills, E. J., Bernhardt, B., Zhou, Q., & Seely, D. (2009). Naturopathic care for anxiety: a randomized controlled trial ISRCTN78958974. PLoS ONE, 4(8), e6628.
17. Pingali, U., Pilli, R., & Fatima, N. (2014). Memory-enhancing activity of Withania somnifera in a rat model of mild cognitive impairment. International Journal of Pharmaceutical Sciences and Research, 5(7), 2647–2652.
18. Kumar, P., Padi, S. S., Naidu, P. S., & Kumar, A. (2007). Effect of Withania somnifera on chronic footshock stress-induced cognitive dysfunction in mice. Phytomedicine, 14(7-8), 470–478.
19. Sehgal, N., Gupta, A., Valli, R. K., Joshi, S. D., Mills, J. T., Hamel, E., & Ravindranath, V. (2012). Withania somnifera reverses Alzheimer’s disease pathology by enhancing low-density lipoprotein receptor-related protein in liver. Proceedings of the National Academy of Sciences, 109(9), 3510–3515.
20. Langade, D., Kanchi, S., Salve, J., Debnath, K., & Ambegaokar, D. (2019). Clinical evaluation of the safety and efficacy of Ashwagandha root extract in insomnia and anxiety: a double-blind, randomized, placebo-controlled study. Cureus, 11(9), e5797.
21. Kaushik, M. K., Kaul, S. C., Wadhwa, R., & Yanagisawa, M. (2017). Triethylene glycol, an active component of Ashwagandha (Withania somnifera), is responsible for sleep induction. PLoS ONE, 12(2), e0172508.
22. Gupte, S., & Khera, A. (2021). Ayurvedic treatment for pediatric ADHD: a pilot observational study. Journal of Ayurveda and Integrative Medicine. https://doi.org/10.1016/j.jaim.2021.01.007
23. Verma, S. K., & Kumar, A. (2011). Therapeutic potential of Withania somnifera against various central nervous system disorders. Journal of Ethnopharmacology, 134(3), 682–690.
24. Müller, N., & Schwarz, M. J. (2007). The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression. Molecular Psychiatry, 12(11), 988–1000.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 American Journal of Psychiatric Rehabilitation
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 International License permitting all use, distribution, and reproduction in any medium, provided the work is properly cited.
This work is licensed under a 
